FindTrial
Sign In

Biorhythm-based study of the mechanism of IBS-D overlapping FD and the pattern of Chinese medicine evidence: a cross-sectional study

Biorhythm-based study of the mechanism of IBS-D overlapping FD and the pattern of Chinese medicine evidence and treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000235
Enrollment
Unknown
Registered
2024-08-14
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IBS-D overlap FD

Interventions

None listed

Sponsors

Guangdong Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Cross-sectional study: (1) Healthy subjects were asked about their medical history and physical examination to exclude cardiovascular and cerebrovascular diseases, diabetes mellitus, hypertension, hyperlipidemia, and other medical history, and exclude intestinal organic lesions; (2) aged 18-65 years; (3) patients meeting the diagnostic criteria of IBS-D, FD; (4) patients with normal cognitive function and no dyslexia, and who were able to actively cooperate with the study; (5) patients who signed an informed consent form; and (6) patients who signed a written consent form. (5) Signed informed consent. Healthy subjects: (1) aged 18-65 years old; (2) without obvious gastrointestinal symptoms such as diarrhoea, constipation, gastric distension, gastric pain; (3) without obvious history of intestinal flora and gastric motivation medication in the last 3 months; (4) with normal cognitive function, without dyslexia, and able to cooperate with the research; (5) signing the informed consent form.

Exclusion criteria

Exclusion criteria: Cross-sectional study: (1) patients with severe cardiac, hepatic, renal and other major organ diseases, haematopoietic, neurological or psychiatric disorders; (2) patients with serious complications or organic diseases of the oesophagus, stomach or intestines; (3) patients with a history of drugs affecting intestinal flora and gastrointestinal motility in the last month; (4) women during pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Self-developed IBS Overlapping FD TCM Evidence-based Characteristics Scale;—

Secondary

MeasureTime frame
clock gene;PHQ-9;Self-developed IBS-D Overlap FD Biorhythm Assessment Scale score;blood metabolite;PADYQ scale scores;PSQI;CAD-7;FD-QOL scale score;clock protein;IBS-QOL scale score;IBS-SSS scale scores;intestinal flora;MEQ-19;VAS;—

Countries

china

Contacts

Public ContactWu Haomeng

Guangdong Hospital of Traditional Chinese Medicine

237925993@qq.com13560228339

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026